Efficacy and Safety of Silfamin for Common Cold With or Without Sore Throat: Preliminary Study
This is a 2-arm, prospective, randomized, double-blind, placebo-controlled, and three-days-treatment clinical study comparing the efficacy and safety of Silfamin at a dose of 2 tablets@150 mg twice daily in subjects with common cold.